インフルエンザの薬にご注意を!
先日、アメリカのHealthDayNewsからの記事です。 インフルエンザの薬のTamifluを飲んだ患者、特に子供に奇妙な症状が出たとのこと。 この秋から3人の死者を含め、奇妙な行動が見られるなどの100以上の新しいケースが、この薬と関連しているのか、インフルエンザでの症状なのかなどFDAでもまだ分かっていません。 Tamifluでの治療は、特にウィルスが潜伏中の時に奇妙な症状を起こすようで、精神かく乱、幻覚その他奇妙な行動が起こりやすくなるとのこと。 ”Many of the pediatric problems have been reported in Japan, where the number of Tamiflu prescriptions is about 10 times greater than in the United States, the AP said” 日本では、アメリカの10倍、処方箋が出されている為たくさんの問題が日本では報告されているとのことです。 インフルエンザにかからないよう極力注意をしましょう! と言っても万が一かかってしまったときは、 どうぞ、処方された薬に気をつけてみたいと思います。 特に、子供用ですね。 皆さん、風邪に気をつけてくださいね☆ ++++ 記事抜粋 ++++ ソースはこちらから頂いてます。 http://health.msn.com/healthnews/articlepage.aspx?cp-documentid=100148674>1=8717 MONDAY, Nov. 13 (HealthDay News) -- Responding to reports from overseas, U.S. heath officials are urging doctors and parents to watch for signs of bizarre behavior in children taking the flu drug Tamiflu. Officials at the U.S. Food and Drug Administration don't know if the more than 100 new cases of strange behavior, including three deaths from falls, are tied to the drug, to the flu itself, or a combination of both, the Associated Press reported. The FDA is mulling changes to the Tamiflu label that may recommend that all patients, especially children, be closely monitored while on the drug. The agency acknowledged that stopping Tamiflu treatment might harm flu patients if the virus is the underlying cause of delirium, hallucinations and other abnormal behavior that make up the symptoms observed in children abroad. Many of the pediatric problems have been reported in Japan, where the number of Tamiflu prescriptions is about 10 times greater than in the United States, the AP said. Although severe cases of flu have been known to produce such side effects, the number and type of cases, plus comments from doctors who believe the abnormal behavior is associated with the drug, are keeping the FDA from ruling out Tamiflu as the cause. The FDA's pediatric advisory committee is to discuss the label recommendation on Thursday, the AP said. The FDA typically follows the advice of its advisory panels.